KAYLEIGH GALLIHER: Open Payments
NPI 1447921291 · MINE HILL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,155 in 61 payments from 13 companies in 2025. Trend: 2023 $51 · 2024 $635 · 2025 $1,155
Food & beverage: $1,155
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $282 |
| Corcept Therapeutics | 15 | $264 |
| AstraZeneca Pharmaceuticals LP | 9 | $168 |
| Phathom Pharmaceuticals, Inc. | 2 | $139 |
| Bausch Health US, LLC | 4 | $70 |
| Axsome Therapeutics, Inc. | 3 | $51 |
| Xeris Pharmaceuticals, Inc. | 3 | $50 |
| ABBVIE INC. | 2 | $34 |
| PFIZER INC. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
Products named: Korlym, Ozempic, VOQUEZNA, FARXIGA, Wegovy, Auvelity, RECORLEV, APLENZIN.
Industry payments across NJ — which companies pay providers there.
